SR ONE CAPITAL MANAGEMENT, LP

Q3 2026 13F-HR Holdings

Location
Redwood City, CA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
17
Total value ($000)
$1,149,540
Net value change ($000)
+110,532 (10.6%)
New positions
3
Sold out positions
1
Turnover %
19.2%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ADARx Pharmaceuticals, Inc. 198,137 NEW
Korsana Biosciences, Inc. 19,645 NEW
Odyssey Therapeutics, Inc. 13,320 18.8%
ORIC 12,184 24.4%
ZBIO 8,010 6.3%
CRSP 1,590 1.4%
ENGN 1,496 NEW
Top Reduces (Value $000, Stocks/ETFs)
MANE -43,113 -14.6%
ALMS -40,667 -73.7%
SPRY -14,847 -46.2%
Avalyn Pharma, Inc -14,658 -13.5%
DSGN -12,400 -13.1%
Mobia Medical, Inc -7,845 -29.5%
OCS -2,904 -32.7%
MLYS -2,894 -6.9%
RARE -2,530 -55.0%
ENGN -1,294 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type